Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Picard Medical, Inc. reported the first quarter ended March 31, 2026 results: revenue $1.2 million, net income $7.6 million.
- Period
- the first quarter ended March 31, 2026
- Revenue
- $1.2 million
- Net income
- $7.6 million
- Result
- reported results
Exact text from the filing
Revenue grew 85% to $1.2 million for the first quarter of 2026
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Picard Medical, Inc. received a nyse_american deficiency notice notice regarding other (rules 1003(a)(ii)).
- Exchange
- nyse american
- Notice
- deficiency notice
- Rules
- 1003(a)(ii)
Exact text from the filing
reviously disclosed, on May 8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together with the May 15 Notice, the “ Notices ”). In connection with the
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Picard Medical, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i)).
- Exchange
- nyse american
- Notice
- deficiency notice
- Deficiency
- stockholders equity
- Rules
- 1003(a)(i)
Exact text from the filing
May 15, 2026, the Company received a written notice (the “May 15 Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standar
View on SEC.gov